TABLE 1.
Demographic and baseline characteristics of sham and repetitive transcranial magnetic stimulation (rTMS) groups.
| Variable | Sham group (n = 68) | rTMS group (n = 68) | t/x2 | p |
| Gender (male/female) | 35/33 | 36/32 | 0.029 | 0.864a |
| Age (years) | 47.265 ± 1.729 | 50.221 ± 1.820 | 1.177 | 0.241 |
| Marital status (single/married/widowed) | 6/58/4 | 7/60/1 | 4.134 | 0.247a |
| Education (years) | 8.058 ± 0.246 | 7.971 ± 0.284 | 0.235 | 0.815 |
| Family history (yes/no) | 4/64 | 5/63 | 0.119 | 0.730a |
| Duration of illness (months) | 44.132 ± 3.048 | 37.206 ± 3.625 | 1.462 | 0.146 |
| First-episode (yes/no) | 27/41 | 24/44 | 0.282 | 0.595 |
| Inpatient care (yes/no) | 20/48 | 29/39 | 2.584 | 0.108a |
| Antidepressants dosage | 1.202 ± 0.0779 | 1.283 ± 0.0970 | 0.63 | 0.52 |
| Kinds of antidepressants (SSRI/SNRI/others) | 19/33/16 | 28/27/13 | 2.634 | 0.268a |
| Antipsychotic dosage | 0.430 ± 0.0456 | 0.385 ± 0.0394 | 0.74 | 0.461 |
| Sleeping dosage | 0.496 ± 0.0874 | 0.528 ± 0.0961 | 0.182 | 0.856 |
| Total score of HAMD-17 | 30.897 ± 0.740 | 30.809 ± 1.003 | 0.071 | 0.944 |
| HAMD-A/S | 9.206 ± 0.280 | 8.853 ± 0.469 | 0.646 | 0.52 |
| HAMD-W | 0.603 ± 0.0598 | 0.618 ± 0.0785 | 0.149 | 0.882 |
| HAMD-CD | 7.632 ± 0.207 | 7.191 ± 0.279 | 1.269 | 0.207 |
| HAMD-R | 9.397 ± 0.237 | 9.397 ± 0.250 | 0.000 | 1.000 |
| HAMD-SD | 4.559 ± 0.131 | 4.750 ± 0.143 | 0.985 | 0.326 |
Values are presented as mean ± SEM.
aChi-square analysis.
rTMS, repetitive transcranial magnetic stimulation; SSRI, selective serotonin reuptake inhibitor; SNRI, serotonin and norepinephrine reuptake inhibitor; HAMD-17, 17 items Hamilton depression rating scale; HAMD-A/S, HAMD-anxiety/somatization factor; HAMD-W, HAMD-weight factor; HAMD-CD, HAMD-cognitive disorder factor; HAMD-R, HAMD-retardation factor; HAMD-SLD, HAMD-sleep disorder factor.